Serum p-Tau217 and apolipoprotein E as potential biomarkers for Alzheimer's disease severity: a case-control study
International Journal of Nutrology · 30.07.2026 · 19 (S3)
DOI: 10.54448/ijn26s315 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift International Journal of Nutrology, online erschienen am 30.07.2026. Verfasst von Ahmed Kadom Kalaf und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Introduction
Alzheimer's disease (AD) is a chronic neurodegenerative illness characterised by aberrant protein accumulation and progressive cognitive decline. One of the most researched blood indicators of tau pathology is phosphorylated tau 217 (p-tau217), and apolipoprotein E (ApoE) is essential for lipid metabolism, amyloid removal, and neuronal maintenance. The severity of AD may be correlated with changes in these biomarkers.
Objective
To compare serum levels of p-tau217 and ApoE in individuals with different severities of Alzheimer's Disease.
Methods
The present case–control study consisted of 156 subjects aged between 55 and 85 years:106 patients with ad (and balanced frequency matched to healthy controls on age, international classification of diseases t63 diagnosis). The DSM-5 criteria classified the patients as mild (n = 12), moderate (n = 50), or severe (n = 44). Using the sandwich enzyme-linked immunosorbent assay (ELISA), the levels of circulating ApoE and p-tau217 were determined. The receiver operating characteristics (ROC) curve examination, Spearman's correlation, and the Kruskal-Wallis test were used in the statistical studies.
Results
The mean serum p-tau217 and ApoE level were 165 ± 84.2 pg/mL and 75.5 ± 55.6 ng/mL, respectively. While serum p-tau217 significantly increased with severity of disease, ApoE levels decreased. We found a significant positive association of p-tau217 (p
Zitieren
APA
Kalaf, A. K., Shemran, K. A., & AlAmeedy, W. A. (2026). Serum p-Tau217 and apolipoprotein E as potential biomarkers for Alzheimer's disease severity: a case-control study. International Journal of Nutrology, 19(S3). https://doi.org/10.54448/ijn26s315
Vancouver
Kalaf AK, Shemran KA, AlAmeedy WA. Serum p-Tau217 and apolipoprotein E as potential biomarkers for Alzheimer's disease severity: a case-control study. International Journal of Nutrology. 2026;19(S3). doi:10.54448/ijn26s315
BibTeX
@article{Kalaf2026,
author = {Kalaf, Ahmed Kadom and Shemran, Khawla A. and AlAmeedy, Waleed Azeez},
title = {Serum p-Tau217 and apolipoprotein E as potential biomarkers for Alzheimer's disease severity: a case-control study},
journal = {International Journal of Nutrology},
year = {2026},
volume = {19},
number = {S3},
doi = {10.54448/ijn26s315}
}
EUVIMED